In this episode of Sustainable Conversations, we speak with James Leavesley, CEO of Dalgety, to explore the opportunities and challenges shaping the medical cannabis industry across the UK and Europe. With regulation evolving and demand growing, James offers an honest look at what it takes to build a science-led, compliant and purpose-driven business in a complex—and often misunderstood—sector.

🌿 Key discussion points:

• The process of entering the medical cannabis market, including essential licences

• Why medical cannabis is not the same as illicit alternatives—and why that matters

• Dalgety’s unique approach to science, patient care and regulatory alignment

• The hurdles UK patients still face in accessing legal medical cannabis

• The importance of collaboration with clinicians, investors and policymakers

• Why education and awareness are crucial for both patients and healthcare professionals

• Dalgety’s long-term vision and how it defines success in a sensitive, high-impact space

📢 This is a must-listen for anyone interested in healthcare innovation, regulatory change or scaling purpose-led ventures in emerging sectors. James’ perspective highlights the vital role of trust, transparency and quality in unlocking access to medical cannabis for those who need it most.

🔗 Listen to the episode on YouTube / Spotify and don’t forget to Like, Share and Subscribe to our channel.